Innoviz Technologies Ltd. INVZ
0.39
0.02
5.41%
as of 25 Sep
- Market cap
- $116.3M
- P/E
- 0.0×
Follow INVZ
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
8.57 | 3.08 | 3.03 | 3.21 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(30.23) | (18.61) | (9.40) | (11.88) | |
P/B ratio |
4.63 | 2.19 | 2.28 | 3.51 | |
Price to Tangible BV |
4.63 | 2.19 | 2.28 | 3.51 | |
EV/Sales |
7.68 | 2.35 | 2.39 | 2.89 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.57) | (2.70) | (2.46) | (2.98) | |
EV/FCF |
(6.10) | (2.62) | (2.41) | (2.94) | |
Quick Ratio |
2.93 | 2.61 | 1.92 | 1.49 | |
Current Ratio |
3.18 | 2.87 | 2.21 | 1.73 | |
Net Debt/EBITDA |
5.15 | 3.77 | 2.39 | 2.82 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.33 | 0.41 | 0.32 | 0.39 | |
Operating CF/Net income |
0.89 | 0.43 | 0.55 | 0.78 | |
Capex/Depreciation |
(0.21) | 1.04 | (1.02) | (0.69) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
80.98% | 127.22% | 234.92% | 64.70% | |
Selling, General and Administrative Expense of Revenue |
37.47% | 54.19% | 114.01% | 41.01% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
25.81% | 32.38% | 52.04% | 21.93% | |
Graham Net Nets |
0.10 | 0.17 | 0.09 | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(17.16%) | (40.00%) | (61.90%) | (50.00%) | |
Free Cash Flow Yield |
(14.69%) | (28.99%) | (32.69%) | (30.64%) | |
Revenue per Share |
0.08 | 0.06 | 0.03 | 0.08 | |
Operating CF per Share |
(0.07) | (0.05) | (0.07) | (0.06) | |
Capex per Share |
0.00 | 0.01 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.07) | (0.04) | (0.07) | (0.07) | |
Cash per Share |
0.37 | 0.36 | 0.28 | 0.22 | |
Shareholders Equity per Share |
0.44 | 0.39 | 0.28 | 0.22 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.44 | 0.39 | 0.28 | 0.22 | |
Free Cash Flow |
(14.01) | (7.26) | (15.80) | (15.23) | |
Working Capital |
70.09 | 58.81 | 41.04 | 30.59 | |
Capital Expenditures |
(0.29) | 1.88 | (1.35) | (0.86) | |
Net Current Asset Value |
40.80 | 29.50 | 12.53 | 1.37 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | (0.15) | 0.19 | 0.05 | |
Net Profit Margin |
(100.92%) | (167.71%) | (367.29%) | (102.45%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
11.68 | 8.01 | 11.48 | 12.70 | |
Average Payables |
7.85 | 8.71 | 7.59 | 9.08 | |
Average Inventory |
2.10 | 2.62 | 2.79 | 4.28 | |
Average Assets |
147.72 | 135.25 | 139.65 | 135.42 | |
Average Common Equity |
91.15 | 78.32 | 83.71 | 70.91 |
Columns are period end dates